To ask Her Majesty's Government what is the absolute value of the increased funding that the National Institute for Health Research will receive over the spending review period.
The Spending Review settlement provides £5 billion over the Spending Review period for health-related research and development (R&D). This includes the largest funding received by health R&D, with an increase of £605 million on 2020-21 funding by 2024-25 which means the investment will rise to £2 billion by the end of the Spending Review period.
The National Institute for Health Research budget will be finalised as part of a detailed financial planning process. The distribution of capital across health R&D areas will be confirmed before funding is made available in April 2022.